OSE Pharma SA Cash Flow-to-Debt Ratio
OSE Pharma SA cash flow-to-debt ratio. OSE Pharma SA (OSE) has a Cash Flow-to-Debt Ratio of -0.34x as of June 2025, meaning its operating cash flow of €-17.98 Million could theoretically repay 0% of its total liabilities (€53.58 Million) in one year. Check OSE Pharma SA cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of OSE Pharma SA (2012–2024)
Cash flow-to-debt ratio of OSE Pharma SA from 2012 to 2024. Historical debt coverage capacity for OSE Pharma SA across 13 annual periods. Check OSE Pharma SA (OSE) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
OSE Pharma SA Cash Flow-to-Debt Ratio by Year (2012–2024)
OSE Pharma SA cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for OSE Pharma SA. For the full cash flow conversion analysis, see OSE cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.81x | €48.44 Million | €60.15 Million | ▲ +340.7% |
| 2023 | -0.33x | €-19.76 Million | €59.08 Million | ▼ -8.4% |
| 2022 | -0.31x | €-18.25 Million | €59.12 Million | ▼ -68.0% |
| 2021 | -0.18x | €-9.92 Million | €53.99 Million | ▲ +66.5% |
| 2020 | -0.55x | €-19.55 Million | €35.61 Million | ▼ -286.0% |
| 2019 | 0.30x | €8.97 Million | €30.40 Million | ▲ +315.1% |
| 2018 | 0.07x | €1.08 Million | €15.15 Million | ▲ +119.5% |
| 2017 | -0.36x | €-8.00 Million | €21.91 Million | ▼ -1435.2% |
| 2016 | 0.03x | €684.00K | €25.02 Million | ▲ +101.5% |
| 2015 | -1.83x | €-4.61 Million | €2.52 Million | ▼ -163.2% |
| 2014 | -0.70x | €-1.94 Million | €2.78 Million | ▼ -253.9% |
| 2013 | -0.20x | €-236.00K | €1.20 Million | ▲ +87.1% |
| 2012 | -1.52x | €-1.39 Million | €915.00K | — |